Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate

Virology

Volumn 350, Issue 1, 2006, Pages 58-66

  Mild, Mattias ^a,c   Björndal, Åsa ^b   Medstrand, Patrik ^c   Fenyö, Eva Maria ^a  

^a LUND UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Biological cloning; Coreceptors; HIV 1

Indexed keywords

CHEMOKINE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS ISOLATION;

AMINO ACID SEQUENCE; CELL LINE; GENOTYPE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33744916576     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.008     Document Type: Article

References (34)

1. Albert J., Naucler A., Bottiger B., Broliden P.A., Albino P., Ouattara S.A., Bjorkegren C., Valentin A., Biberfeld G., and Fenyo E.M. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS 4 4 (1990) 291-295
2. Asjo B., Morfeldt-Manson L., Albert J., Biberfeld G., Karlsson A., Lidman K., and Fenyo E.M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2 8508 (1986) 660-662
3. Beaumont T., Quakkelaar E., van Nuenen A., Pantophlet R., and Schuitemaker H. Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker. J. Virol. 78 11 (2004) 5651-5657
4. Berger E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11 Suppl. A (1997) S3-S16
5. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., and Weiss R.A. A new classification for HIV-1. Nature 391 6664 (1998) 240
6. Bjorndal A., Deng H., Jansson M., Fiore J.R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D.R., and Fenyo E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71 10 (1997) 7478-7487
7. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., and Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 94 5 (1997) 1925-1930
8. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., and Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 7 (1996) 1135-1148
9. Connor R.I., Sheridan K.E., Ceradini D., Choe S., and Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-Infected individuals. J. Exp. Med. 185 4 (1997) 621-628
10. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., and Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 5996 (1984) 763-767
11. De Jong J.J., De Ronde A., Keulen W., Tersmette M., and Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66 11 (1992) 6777-6780
12. de Jong J.J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., and de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66 2 (1992) 757-765
13. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., and Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 6584 (1996) 661-666
14. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., and Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 7 (1996) 1149-1158
15. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 5263 (1996) 872-877
16. Fenyo E.M., Morfeldt-Manson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., and Asjo B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62 11 (1988) 4414-4419
17. Folks T., Kelly J., Benn S., Kinter A., Justement J., Gold J., Redfield R., Sell K.W., and Fauci A.S. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J. Immunol. 136 11 (1986) 4049-4053
18. Fouchier R.A., Groenink M., Kootstra N.A., Tersmette M., Huisman H.G., Miedema F., and Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66 5 (1992) 3183-3187
19. Fouchier R.A., Brouwer M., Broersen S.M., and Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 33 4 (1995) 906-911
20. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 4760 (1986) 215-219
21. Karlsson A., Parsmyr K., Aperia K., Sandstrom E., Fenyo E.M., and Albert J. MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. J. Infect. Dis. 170 6 (1994) 1367-1375
22. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., and Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312 5996 (1984) 767-768
23. Koot M., Keet I.P., Vos A.H., de Goede R.E., Roos M.T., Coutinho R.A., Miedema F., Schellekens P.T., and Tersmette M. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118 9 (1993) 681-688
24. Leitner T., Halapi E., Scarlatti G., Rossi P., Albert J., Fenyo E.M., and Uhlen M. Analysis of heterogeneous viral populations by direct DNA sequencing. BioTechniques 15 1 (1993) 120-127
25. Leitner T., Korovina G., Marquina S., Smolskaya T., and Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res. Hum. Retroviruses 12 17 (1996) 1595-1603
26. Poignard P., Saphire E.O., Parren P.W., and Burton D.R. gp120: Biologic aspects of structural features. Annu. Rev. Immunol. 19 (2001) 253-274
27. Sawyer L.S., Wrin M.T., Crawford-Miksza L., Potts B., Wu Y., Weber P.A., Alfonso R.D., and Hanson C.V. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68 3 (1994) 1342-1349
28. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E.M., and Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3 11 (1997) 1259-1265
29. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., and Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66 3 (1992) 1354-1360
30. Shioda T., Levy J.A., and Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 89 20 (1992) 9434-9438
31. Tersmette M., de Goede R.E., Al B.J., Winkel I.N., Gruters R.A., Cuypers H.T., Huisman H.G., and Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62 6 (1988) 2026-2032
32. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 24 (1997) 4876-4882
33. Yu X.F., Wang Z., Vlahov D., Markham R.B., Farzadegan H., and Margolick J.B. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J. Infect. Dis. 178 2 (1998) 388-396
34. Zhang Y.J., Fredriksson R., McKeating J.A., and Fenyo E.M. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. Virology 238 2 (1997) 254-264